Patent ID: 8680155

Claim:
A pharmaceutical composition for treating a cancer, comprising a bis(benzylidene-benzenamine)disulfide represented by formula I: wherein the ring A comprises an R1, an R2, an R3 and an R4 bound thereon, R1 is one selected from the group consisting of a hydrogen, CH 3 , C 2 H 5 , C 3 H 7 , C 4 H 9 , C 5 H 11 and C 6 H 13 , R2 is one of a hydrogen and a nitrite, R3 is one selected from the group consisting of a hydrogen, a nitrite, CF 3 , a halide, CH 3 , C 2 H 5 , C 3 H 7 , C 4 H 9 , C 5 H 11 and C 6 H 13 , R4 is one of a hydrogen and a nitrite, the ring B comprises an R5 and an R6 bound thereon, R5 is one selected from the group consisting of a hydrogen, CH 3 , C 2 H 5 , C 3 H 7 , C 4 H 9 , C 5 H 11 , C 6 H 13 , OCH 3 , OC 2 H 5 , OC 3 H 7 , OC 4 H 9 , OC 5 H 11 and OC 6 H 13 , R6 is one selected from the group consisting of a hydrogen, a nitrite, CF 3 and a halide and the halide is selected from the group consisting of fluoride, chloride, bromide and iodine.